Derivatives of 4-(n-azacycloalkyl) anilides as potassium...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/04 (2006.01) A61K 31/4725 (2006.01) A61P 25/08 (2006.01) C07D 401/14 (2006.01) C07D 405/14 (2006.01) C07D 413/14 (2006.01) C07D 471/04 (2006.01)

Patent

CA 2689208

This invention provides potassium channel modulators which are compounds of formula (I), (formula I), where at least one of W and Z is N; where the moiety (formula II), is one of Groups A or B below (formula A), where Ar is a 1,2-fused, six membered ring aromatic group, bearing substituents R1 and R2 as defined below, and containing zero or one ring nitrogen atom; and where other substituents are defined herein. The invention also provides a composition comprising a pharmaceutically acceptable carrier and at least one of the following: i) a pharmaceutically effective amount of a compound of formula I and ii) a pharmaceutically acceptable salt, ester, or prodrug thereof. The invention also provides a method of preventing or treating a disease or disorder which is affected by activities of potassium channels, comprising administering to a patient in need thereof a therapeutically effective amount of a compound of formula I or a salt, ester, or prodrug thereof.

L'invention concerne des modulateurs de canal potassium qui sont des composés de formule (I), (formule I), dans laquelle au moins un parmi W et Z est de l'azote ; dans laquelle le groupe caractéristique (formule II), est un groupe parmi les groupes A ou B ci-dessous (formule A), où Ar est un groupe aromatique cyclique hexagonal 1,2-fondu, portant des substituants R1 et R2 tels que définis ci-dessous, et contenant 0 ou un atome d'azote de cycle ; d'autres substituants étant définis ici. L'invention concerne également une composition comprenant un support pharmaceutiquement acceptable et au moins un composant parmi les suivants : i) une quantité pharmaceutiquement efficace d'un composé de formule I, et ii) un sel pharmaceutiquement acceptable, un ester, ou un promédicament de celui-ci. L'invention fournit également un procédé de prévention ou de traitement d'une maladie ou d'un trouble qui est affecté par les activités des canaux potassium, comprenant l'administration à un patient le nécessitant d'une quantité thérapeutiquement efficace d'un composé de formule I ou d'un sel, d'un ester, ou d'un promédicament de celui-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Derivatives of 4-(n-azacycloalkyl) anilides as potassium... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Derivatives of 4-(n-azacycloalkyl) anilides as potassium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 4-(n-azacycloalkyl) anilides as potassium... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1489320

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.